Aneesh K. Mehta
Emory University
H-index: 48
North America-United States
Top articles of Aneesh K. Mehta
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Immunomodulators for immunocompromised patients hospitalized for COVID-19: a meta-analysis of randomized controlled trials | EClinicalMedicine | Ilias I Siempos Andre C Kalil Drifa Belhadi Viviane Cordeiro Veiga Alexandre Biasi Cavalcanti | 2024/3/1 |
Select Agent Regulatory Challenges in a Patient Care Setting: Review and Recommendations | Megan C Mears Corrie A Ntiforo Lauren M Sauer Aneesh K Mehta Corri B Levine | 2024/2/1 | |
Fecal microbiota transplantation promotes reduction of antimicrobial resistance by strain replacement | Science Translational Medicine | Michael H Woodworth Roth E Conrad Marina Haldopoulos Stephanie M Pouch Ahmed Babiker | 2023/11/1 |
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case | Open forum infectious diseases | Ana M Ortega-Villa Noreen A Hynes Corri B Levine Katherine Yang Zanthia Wiley | 2023/6 |
Temporal improvements in COVID-19 outcomes for hospitalized adults: a post hoc observational study of remdesivir group participants in the adaptive COVID-19 treatment trial | Annals of internal medicine | Gail E Potter Tyler Bonnett Kevin Rubenstein David A Lindholm Rekha R Rapaka | 2022/12 |
Reply to author | Clinical Infectious Diseases | Zanthia Wiley Katie Ross-Driscoll Zhensheng Wang Laken Smothers Aneesh K Mehta | 2022/2/1 |
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States | Clinical infectious diseases | William A Werbel Diane M Brown Oyinkansola T Kusemiju Brianna L Doby Shanti M Seaman | 2022/6/1 |
Deconstructing the treatment effect of remdesivir in the adaptive coronavirus disease 2019 (COVID-19) treatment trial-1: implications for critical care resource utilization | Clinical Infectious Diseases | Jonathan Fintzi Tyler Bonnett Daniel A Sweeney Nikhil A Huprikar Anuradha Ganesan | 2022/6/15 |
Impact of belatacept and tacrolimus on cytomegalovirus viral load control and relapse in moderate and high‐risk cytomegalovirus serostatus kidney transplant recipients | Transplant Infectious Disease | Wairimu Magua Aileen C Johnson Geeta M Karadkhele Idelberto R Badell Payaswini Vasanth | 2022/12 |
Racial and ethnic differences and clinical outcomes of patients with coronavirus disease 2019 (COVID-19) presenting to the emergency department | Clinical Infectious Diseases | Zanthia Wiley Katie Ross-Driscoll Zhensheng Wang Laken Smothers Aneesh K Mehta | 2022/2/1 |
Comparison of Tacrolimus Serum Levels During First Month After Lung Transplant in Patients with and without Gastroparesis | The Journal of Heart and Lung Transplantation | M Mubashir J Rappaport H Siddiqui J Barron B Kramer | 2022/4/1 |
The evolution of the national special pathogen system of care | Health security | Vikramjit Mukherjee Lauren M Sauer Aneesh K Mehta Sophia Y Shea Paul D Biddinger | 2022/6/1 |
PI3Kδ/γ Inhibitor Duvelisib Modulates Inflammatory Profile in Severe COVID-19 Patients: Results from a Randomized Placebo-Controlled Phase 2 Study | Blood | Hanwen Zhang Shuhua Wang Manali Rupji Chenxi Wu Sanjay Chandrasekaran | 2022/11/15 |
Severe monkeypox in hospitalized patients—United States, August 10–october 10, 2022 | MMWR. Morbidity and mortality weekly report | Maureen J Miller | 2022 |
HOPE in action: a prospective multicenter pilot study of liver transplantation from donors with HIV to recipients with HIV | American journal of transplantation | Christine M Durand Sander Florman Jennifer D Motter Diane Brown Darin Ostrander | 2022/3 |
Prepared to act: lessons learned by the special pathogens research network, based on collaborations with the NIAID-led adaptive COVID-19 treatment trial | Health security | Corri B Levine Sami Vasistha Caroline Croyle Persson LuAnn R Larson Christopher J Kratochvil | 2022/6/1 |
Phenotypes of disease severity in a cohort of hospitalized COVID-19 patients: results from the IMPACC study | EBioMedicine | Al Ozonoff Joanna Schaenman Naresh Doni Jayavelu Carly E Milliren Carolyn S Calfee | 2022/9/1 |
Fecal microbiota transplantation donor screening updates and research gaps for solid organ transplant recipients | Nirja Mehta Tiffany Wang Rachel J Friedman-Moraco Cynthia Carpentieri Aneesh K Mehta | 2022/2/16 | |
Contributions of the regional emerging special pathogen treatment centers to the US COVID-19 pandemic response | Health security | Jonathan D Grein Jennifer A Garland Christa Arguinchona Maria G Frank Brian T Garibaldi | 2022/6/1 |
Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial | The lancet respiratory medicine | Cameron R Wolfe Kay M Tomashek Thomas F Patterson Carlos A Gomez Vincent C Marconi | 2022/9/1 |
Co-Authors
